| Perspective |
Component of cost |
Approach |
Measure |
Calculation model |
| Provider |
cost of hospitalization |
Step down |
average cost of hospitalization per patient per day |
(60% x average recurrent cost) / total number of inpatients day |
|
|
Step down |
average cost per patient per visit |
(40% x recurrent cost) / number of patient’s visit at outpatient clinics |
|
|
|
|
|
|
drug cost |
ABC |
average cost per drug per patient per treatment |
average cost per unit drug x utilization |
|
cost laboratory investigation |
ABC |
average cost per laboratory investigation per patient per treatment |
average cost per test x utilization |
|
cost of procedural examination |
|
average cost per examination per patient per treatment |
average cost per test x utilization |
|
|
|
|
|
| Patient |
transportation cost |
ABC |
average transportation cost per patient per treatment |
expenses of transportation (to and fro) |
|
loss of productivity |
ABC |
average loss of productivity per patient per treatment |
income (daily) x days of patients unable to work because of psoriasis in a month |
| Societal |
Component cost provider + component cost patient |
Step down + ABC |
average cost per patient per treatment |
average cost borne by patient + average cost borne by patient |
|
|
|
|
|
| Economic burden |
- |
- |
average cost per patient |
total cost (societal) x prevalence of psoriasis (year 2015) |
|
|
|
|
|
| Effectiveness analysis |
- |
- |
percentage of patients achieving PASI-75 and/or BSA<5 and/or DLQI≤5, 6 months after treatment is initiated |
number of patients achieving PASI-75 and/or BSA<5 and/or DLQI≤5) / total number of patients treated with particular treatment |
|
|
|
|
|
| Cost effectiveness analysis |
- |
- |
Average cost per PASI-75 and/or BSA<5 and/or DLQI≤5 |
average cost per treatment / effectiveness |
